Robotic-assisted laparoscopic myomectomy and abdominal myomectomy to manage uterine fibroids were equally effective in improving symptoms, but each procedure has its own benefits.
There is little difference in the effectiveness and safety of laparoendoscopic single-site surgery and conventional laparoscopic surgery for the treatment of gynecological diseases.
After minimally invasive laparoscopic surgery, gum chewing has beneficial effects on bowel motility when used as an adjunct treatment in postoperative care, according to the results of a randomized controlled trial.
Laparoendoscopic single-site surgery with hysterectomy (LESS-H) for benign disease with either a lateral or vaginal approach is a feasible procedure regardless of cesarean section history.
This surgical video shows resection of a 3-cm intracavity fibroid using minimally invasive surgical technology. The patient, a 40-year-old woman, presented with a 60-day history of abnormal bleeding.
This patient presented with 18 months of secondary infertility following a second trimester dilation and extraction.
The use of a postoperative levonorgestrel-releasing intrauterine device reduces the recurrence of painful periods in women with endometriosis.
The use of robotically assisted hysterectomy for women with benign gynecological disease offers little short-term benefit and has significantly greater costs than laparoscopic hysterectomy, according to the results of a large US cohort study.
Continuous infusion of the NSAID ketorolac, a powerful nonopioid analgesic, is a safe therapeutic option for the management of postoperative pain, concludes a double-blind randomized controlled trial.
Prophylactic dexamethasone decreases the incidence of postoperative nausea and vomiting without causing observable adverse effects in patients after laparoscopic gynecological surgery, concludes a new meta-analytic review.